Author

Javaria Mona Khalid 1

1 Takeda Development Centre Europe Ltd, London, United Kingdom

HOSPITALISATIONS AND TREATMENT DISCONTINUATION AMONG PATIENTS WITH ULCERATIVE COLITIS AND CROHN?S DISEASE TREATED WITH VEDOLIZUMAB COMPARED WITH INFLIXIMAB

Mireia Raluy Callado, Naufil Alam, Rosa Wang, Javaria Mona Khalid

PATTERNS OF DOSE ESCALATION AMONGST PATIENTS WITH ULCERATIVE COLITIS AND CROHN?S DISEASE TREATED WITH VEDOLIZUMAB VS. INFLIXIMAB IN THE UNITED STATES (US)

Mireia Raluy Callado, Qian Li, Michelle Luo, Karen Lasch, Javaria Mona Khalid

PREDICTORS OF NON-RESPONSE OR LOSS OF RESPONSE TO TUMOUR NECROSIS FACTOR ANTAGONIST THERAPIES IN INFLAMMATORY BOWEL DISEASE

Laurent Peyrin-Biroulet, Alessandro Armuzzi, Javier Gisbert, Geoffrey C. Nguyen, Bernd Bokemeyer, James Lindsay, Michael Smyth, Melvin Munsaka, Sreeram Ramagopalan, Javaria Mona Khalid

REAL WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS

Stefan Schreiber, Axel Dignass, Laurent Peyrin-Biroulet, Mahmoud Mosli, Greg Hather, Dirk Demuth, Aimee Blake, Rebecca Curtis, Javaria Mona Khalid, Edward V Loftus Jr

REAL-WORLD CHARACTERISTICS OF THE FIRST USERS OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS IN ISRAEL

Clara Weil, Gabriel Chodick, Adva Yarden, Karolina Minda, Javaria Mona Khalid, Varda Shalev

REAL-WORLD EPIDEMIOLOGY AND INITIAL TREATMENT PATTERNS OF PATIENTS NEWLY DIAGNOSED WITH INFLAMMATORY BOWEL DISEASE IN ISRAEL

Clara Weil, Gabriel Chodick, Adva Yarden, Javaria Mona Khalid, Varda Shalev

SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN ADULT ULCERATIVE COLITIS AND CROHN?S DISEASE PATIENTS

Sandra M Bovens, Angela Solaman, Rebecca Curtis, Sharon O'Byrne, Javaria Mona Khalid, Dirk Demuth

THE INCIDENCE OF AND TIME TO SUBOPTIMAL THERAPY AMONG PATIENTS WITH ULCERATIVE COLITIS AND CROHN?S DISEASE INITIATING TUMOUR NECROSIS FACTOR ANTAGONISTS: A MULTI-COUNTRY CHART REVIEW

Alessandro Armuzzi, James Lindsay, Haridarshan Patel, Bernd Bokemeyer, Javier Gisbert, Geoffrey C. Nguyen, Laurent Peyrin-Biroulet, Michael Smyth, Javaria Mona Khalid

THE INCIDENCE OF SUBOPTIMAL THERAPY AFTER INITIATING A SECOND TUMOUR NECROSIS FACTOR ANTAGONIST IN PATIENTS WITH CROHN?S DISEASE: A MULTI-COUNTRY CHART REVIEW

Javier Gisbert, Laurent Peyrin-Biroulet, Geoffrey C. Nguyen, Bernd Bokemeyer, Alessandro Armuzzi, James Lindsay, Ines Pree, Haridarshan Patel, Javaria Mona Khalid

THE INCIDENCE OF SUBOPTIMAL THERAPY AFTER INITIATING A SECOND TUMOUR NECROSIS FACTOR ANTAGONIST IN PATIENTS WITH ULCERATIVE COLITIS: A MULTI-COUNTRY CHART REVIEW

James Lindsay, Javier Gisbert, Haridarshan Patel, Laurent Peyrin-Biroulet, Alessandro Armuzzi, Bernd Bokemeyer, Geoffrey C. Nguyen, Ines Pree, Javaria Mona Khalid

Item 1 - 10 / 12
1
2